Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mariko Morishita
Feasibility and Efficacy of Adjuvant Chemotherapy With a Split-Dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients With Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer -A Retrospective Analysis-
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Related publications
Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients With Non-Small Cell Lung Cancer
Oncomedicine
P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Feasibility of Adjuvant Chemotherapy With S-1 Consisting of a 4-Week Administration and a Two-Week Rest Period in Patients With Completely Resected Non-Small Cell Lung Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program
Clinical Cancer Research
Cancer Research
Oncology
A Phase I/Ii Study of Weekly Nab-Paclitaxel Plus Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary